NCT02504151View on ClinicalTrials.gov

Cannabidiol Treatment in Patients With Early Psychosis

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 28, 2016

Primary Completion Date

March 2, 2018

Study Completion Date

March 9, 2018

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

Cannabidiol

DRUG

Placebo

Trial Locations (2)

06519

Connecticut Mental Health Center, New Haven

06516

VA Connecticut Healthcare System, West Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT02504151 - Cannabidiol Treatment in Patients With Early Psychosis | Biotech Hunter | Biotech Hunter